24/7 Wall St. on MSN57m
Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
Miami's Community Newspapers22m
Should you get on the Ozempic bandwagon?
A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down ...